Kintor Pharmaceutical Limited 9939.HK Stock
Kintor Pharmaceutical Limited Price Chart
Kintor Pharmaceutical Limited 9939.HK Financial and Trading Overview
Kintor Pharmaceutical Limited stock price | 0.87 HKD |
Previous Close | 4.07 HKD |
Open | 4.09 HKD |
Bid | 4.16 HKD x N/A |
Ask | 4.17 HKD x N/A |
Day's Range | 4 - 4.44 HKD |
52 Week Range | 3.54 - 21.7 HKD |
Volume | 8.56M HKD |
Avg. Volume | 5.29M HKD |
Market Cap | 1.87B HKD |
Beta (5Y Monthly) | -0.036717 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.68 HKD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.92 HKD |
9939.HK Valuation Measures
Enterprise Value | 1.11B HKD |
Trailing P/E | N/A |
Forward P/E | -2.3038676 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.2481292 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.165 |
Trading Information
Kintor Pharmaceutical Limited Stock Price History
Beta (5Y Monthly) | -0.036717 |
52-Week Change | -79.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 21.7 HKD |
52 Week Low | 3.54 HKD |
50-Day Moving Average | 4.94 HKD |
200-Day Moving Average | 9.78 HKD |
9939.HK Share Statistics
Avg. Volume (3 month) | 5.29M HKD |
Avg. Daily Volume (10-Days) | 4.41M HKD |
Shares Outstanding | 447.5M |
Float | 311.76M |
Short Ratio | N/A |
% Held by Insiders | 31.26% |
% Held by Institutions | 9.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -29.38% |
Return on Equity (ttm) | -60.58% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -956446016 HKD |
Net Income Avi to Common (ttm) | -954369024 HKD |
Diluted EPS (ttm) | -2.94 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 876.96M HKD |
Total Cash Per Share (mrq) | 1.96 HKD |
Total Debt (mrq) | 286.39M HKD |
Total Debt/Equity (mrq) | 19.15 HKD |
Current Ratio (mrq) | 4.74 |
Book Value Per Share (mrq) | 3.341 |
Cash Flow Statement
Operating Cash Flow (ttm) | -961260032 HKD |
Levered Free Cash Flow (ttm) | -681669376 HKD |
Profile of Kintor Pharmaceutical Limited
Country | Hong Kong |
State | N/A |
City | Suzhou |
Address | No. 20 Songbei Road |
ZIP | 215123 |
Phone | 86 51 2626 39909 |
Website | https://www.kintor.com.cn |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 301 |
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline comprises ALK-1 antibody for the treatment of metastatic hepatocellular carcinoma (HCC) and various solid tumours; GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris; and PD-L1/TGF-ß, a dual target antibody to treat non-small cell lung cancer, biliary tract cancer, triple negative breast cancer, and HPV-associated tumours. In addition, the company's products pipeline include Detorsertib for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and HCC; and Hedgehog/SMO Inhibitor, an inhibitor of the hedgehog signal transduction pathway to treat blood cancer. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.
Q&A For Kintor Pharmaceutical Limited Stock
What is a current 9939.HK stock price?
Kintor Pharmaceutical Limited 9939.HK stock price today per share is 0.87 HKD.
How to purchase Kintor Pharmaceutical Limited stock?
You can buy 9939.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kintor Pharmaceutical Limited?
The stock symbol or ticker of Kintor Pharmaceutical Limited is 9939.HK.
Which industry does the Kintor Pharmaceutical Limited company belong to?
The Kintor Pharmaceutical Limited industry is Biotechnology.
How many shares does Kintor Pharmaceutical Limited have in circulation?
The max supply of Kintor Pharmaceutical Limited shares is 447.5M.
What is Kintor Pharmaceutical Limited Price to Earnings Ratio (PE Ratio)?
Kintor Pharmaceutical Limited PE Ratio is now.
What was Kintor Pharmaceutical Limited earnings per share over the trailing 12 months (TTM)?
Kintor Pharmaceutical Limited EPS is -2.68 HKD over the trailing 12 months.
Which sector does the Kintor Pharmaceutical Limited company belong to?
The Kintor Pharmaceutical Limited sector is Healthcare.
Kintor Pharmaceutical Limited 9939.HK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}